LRP5 and LRP6, as coreceptors of PCSK9, promote atherosclerosis by activating the Wnt/β-catenin signaling pathway, resulting in significant proliferation of VSMCs and decreased anti-inflammatory macrophages (78, 81). The gene discussed is PCSK9; the disease is atherosclerosis.